Literature DB >> 2420925

Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee.

P D Minor, A John, M Ferguson, J P Icenogle.   

Abstract

A 4 month old child was immunized with a vaccine containing the Sabin live attenuated vaccine strains of all three serotypes of poliovirus. The antigenic and molecular evolution of the Sabin strain of poliovirus type 3 was then followed throughout the entire period of virus excretion. Novel strains appeared at 8, 42 and 52 days post-vaccination and were the products of both intertypic recombination between type 2 and type 3 poliovirus in regions of the genome coding for non-structural proteins and of point mutations in the region coding for the structural proteins. Excretion of virus continued for 73 days. All strains examined reacted with all monoclonal antibodies specific for the main immunodominant antigenic site of type 3 poliovirus, but variation was observed at other, immunorecessive sites. These findings have possible implications for the evolution of the virus in vaccinees or in epidemics and are consistent with the known antigenic stability of the virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420925     DOI: 10.1099/0022-1317-67-4-693

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  56 in total

1.  Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.

Authors:  G V Gavrilin; E A Cherkasova; G Y Lipskaya; O M Kew; V I Agol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein.

Authors:  Mauro Costa-Mattioli; Juan Cristina; Héctor Romero; Raoul Perez-Bercof; Didier Casane; Rodney Colina; Laura Garcia; Ines Vega; Graciela Glikman; Victor Romanowsky; Alejandro Castello; Elisabeth Nicand; Michelle Gassin; Sylviane Billaudel; Virginie Ferré
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

3.  Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors:  Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Recombination of poliovirus RNA proceeds in mixed replication complexes originating from distinct replication start sites.

Authors:  Denise Egger; Kurt Bienz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Enteroviruses in recreational waters of Northern Ireland.

Authors:  M S Hughes; P V Coyle; J H Connolly
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

6.  Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses.

Authors:  J J Holland; J C de la Torre; D K Clarke; E Duarte
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Comparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehyde.

Authors:  M Chambon; C Jallat-Archimbaud; J L Bailly; J M Gourgand; F Charbonne; C Henquell; F Fuchs; H Peigue-Lafeuille
Journal:  Appl Environ Microbiol       Date:  1997-08       Impact factor: 4.792

8.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Recombination in circulating enteroviruses.

Authors:  Alexander N Lukashev; Vasilii A Lashkevich; Olga E Ivanova; Galina A Koroleva; Ari E Hinkkanen; Jorma Ilonen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; F Delpeyroux; M Tardy-Panit; J Balanant; M Combiescu; A A Combiescu; S Guillot; R Crainic
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.